Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Proc Natl Acad Sci U S A ; 117(8): 4169-4179, 2020 02 25.
Artículo en Inglés | MEDLINE | ID: mdl-32029597

RESUMEN

Abscission is the terminal step of cytokinesis leading to the physical separation of the daughter cells. In response to the abnormal presence of lagging chromatin between dividing cells, an evolutionarily conserved abscission/NoCut checkpoint delays abscission and prevents formation of binucleated cells by stabilizing the cytokinetic intercellular bridge (ICB). How this bridge is stably maintained for hours while the checkpoint is activated is poorly understood and has been proposed to rely on F-actin in the bridge region. Here, we show that actin polymerization is indeed essential for stabilizing the ICB when lagging chromatin is present, but not in normal dividing cells. Mechanistically, we found that a cytosolic pool of human methionine sulfoxide reductase B2 (MsrB2) is strongly recruited at the midbody in response to the presence of lagging chromatin and functions within the ICB to promote actin polymerization there. Consistently, in MsrB2-depleted cells, F-actin levels are decreased in ICBs, and dividing cells with lagging chromatin become binucleated as a consequence of unstable bridges. We further demonstrate that MsrB2 selectively reduces oxidized actin monomers and thereby counteracts MICAL1, an enzyme known to depolymerize actin filaments by direct oxidation. Finally, MsrB2 colocalizes and genetically interacts with the checkpoint components Aurora B and ANCHR, and the abscission delay upon checkpoint activation by nuclear pore defects also depends on MsrB2. Altogether, this work reveals that actin reduction by MsrB2 is a key component of the abscission checkpoint that favors F-actin polymerization and limits tetraploidy, a starting point for tumorigenesis.


Asunto(s)
Actinas/metabolismo , Cromatina/metabolismo , Citocinesis/fisiología , Proteínas de Drosophila/metabolismo , Metionina Sulfóxido Reductasas/metabolismo , Proteínas de Microfilamentos/metabolismo , Mitosis/fisiología , Animales , Línea Celular , Drosophila , Proteínas de Drosophila/genética , Complejos de Clasificación Endosomal Requeridos para el Transporte/metabolismo , Células HeLa , Humanos , Metionina Sulfóxido Reductasas/genética , Proteínas de Microfilamentos/genética , Oxigenasas de Función Mixta/genética , Oxigenasas de Función Mixta/metabolismo , Oxidación-Reducción
2.
PLoS Pathog ; 11(4): e1004877, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25923723

RESUMEN

Viral invasion into a host is initially recognized by the innate immune system, mainly through activation of the intracellular cytosolic signaling pathway and coordinated activation of interferon regulatory factor 3 (IRF3) and nuclear factor kappa B (NF-κB) transcription factors that promote type I interferon gene induction. The TANK-binding Kinase 1 (TBK1) phosphorylates and activates IRF3. Here, we show that Optineurin (Optn) dampens the antiviral innate immune response by targeting the deubiquitinating enzyme CYLD to TBK1 in order to inhibit its enzymatic activity. Importantly, we found that this regulatory mechanism is abolished at the G2/M phase as a consequence of the nuclear translocation of CYLD and Optn. As a result, we observed, at this cell division stage, an increased activity and phosphorylation of TBK1 that lead to its relocalization to mitochondria and to enhanced interferon production, suggesting that this process, which relies on Optn function, might be of major importance to mount a preventive antiviral response during mitosis.


Asunto(s)
Inmunidad Innata , Interferón beta/metabolismo , Mitosis , Proteínas Serina-Treonina Quinasas/metabolismo , Factor de Transcripción TFIIIA/metabolismo , Proteínas Supresoras de Tumor/metabolismo , Regulación hacia Arriba , Transporte Activo de Núcleo Celular , Sustitución de Aminoácidos , Proteínas de Ciclo Celular , Línea Celular , Enzima Desubiquitinante CYLD , Fase G2 , Genes Reporteros , Humanos , Interferón beta/genética , Proteínas de Transporte de Membrana , Mutación , Fosforilación , Procesamiento Proteico-Postraduccional , Proteínas Serina-Treonina Quinasas/antagonistas & inhibidores , Proteínas Serina-Treonina Quinasas/química , Proteínas Serina-Treonina Quinasas/genética , Transporte de Proteínas , Interferencia de ARN , ARN Interferente Pequeño , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Factor de Transcripción TFIIIA/antagonistas & inhibidores , Factor de Transcripción TFIIIA/genética , Proteínas Supresoras de Tumor/agonistas , Proteínas Supresoras de Tumor/antagonistas & inhibidores , Proteínas Supresoras de Tumor/genética
3.
Dev Cell ; 58(22): 2477-2494.e8, 2023 Nov 20.
Artículo en Inglés | MEDLINE | ID: mdl-37875118

RESUMEN

Cilia protrude from the cell surface and play critical roles in intracellular signaling, environmental sensing, and development. Reduced actin-dependent contractility and intracellular trafficking are both required for ciliogenesis, but little is known about how these processes are coordinated. Here, we identified a Rac1- and Rab35-binding protein with a truncated BAR (Bin/amphiphysin/Rvs) domain that we named MiniBAR (also known as KIAA0355/GARRE1), which plays a key role in ciliogenesis. MiniBAR colocalizes with Rac1 and Rab35 at the plasma membrane and on intracellular vesicles trafficking to the ciliary base and exhibits fast pulses at the ciliary membrane. MiniBAR depletion leads to short cilia, resulting from abnormal Rac-GTP/Rho-GTP levels and increased acto-myosin-II-dependent contractility together with defective trafficking of IFT88 and ARL13B into cilia. MiniBAR-depleted zebrafish embryos display dysfunctional short cilia and hallmarks of ciliopathies, including left-right asymmetry defects. Thus, MiniBAR is a dual Rac and Rab effector that controls both actin cytoskeleton and membrane trafficking for ciliogenesis.


Asunto(s)
Proteínas del Citoesqueleto , Pez Cebra , Animales , Pez Cebra/metabolismo , Proteínas del Citoesqueleto/metabolismo , Transducción de Señal , Proteínas Portadoras/metabolismo , Cilios/metabolismo , Guanosina Trifosfato/metabolismo , Proteínas de Unión al GTP rab/metabolismo
5.
Nat Commun ; 11(1): 1941, 2020 04 22.
Artículo en Inglés | MEDLINE | ID: mdl-32321914

RESUMEN

Cytokinesis requires the constriction of ESCRT-III filaments on the side of the midbody, where abscission occurs. After ESCRT recruitment at the midbody, it is not known how the ESCRT-III machinery localizes to the abscission site. To reveal actors involved in abscission, we obtained the proteome of intact, post-abscission midbodies (Flemmingsome) and identified 489 proteins enriched in this organelle. Among these proteins, we further characterized a plasma membrane-to-ESCRT module composed of the transmembrane proteoglycan syndecan-4, ALIX and syntenin, a protein that bridges ESCRT-III/ALIX to syndecans. The three proteins are highly recruited first at the midbody then at the abscission site, and their depletion delays abscission. Mechanistically, direct interactions between ALIX, syntenin and syndecan-4 are essential for proper enrichment of the ESCRT-III machinery at the abscission site, but not at the midbody. We propose that the ESCRT-III machinery must be physically coupled to a membrane protein at the cytokinetic abscission site for efficient scission, uncovering common requirements in cytokinesis, exosome formation and HIV budding.


Asunto(s)
Proteínas de Unión al Calcio/metabolismo , Proteínas de Ciclo Celular/metabolismo , Membrana Celular/metabolismo , Citocinesis , Complejos de Clasificación Endosomal Requeridos para el Transporte/metabolismo , Orgánulos/metabolismo , Sindecano-4/metabolismo , Sinteninas/metabolismo , Proteínas de Unión al Calcio/genética , Proteínas de Ciclo Celular/genética , Membrana Celular/genética , Complejos de Clasificación Endosomal Requeridos para el Transporte/genética , Endosomas/genética , Endosomas/metabolismo , Células HeLa , Humanos , Orgánulos/genética , Unión Proteica , Sindecano-4/genética , Sinteninas/genética
6.
Infect Genet Evol ; 7(5): 604-8, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17586100

RESUMEN

During fall 2005, the rapid and wide spread of highly pathogenic (HP) H5N1 avian influenza viruses (AIV) outside Asia alerted European health authorities. Because of abnormal and recurrent field mortality, wild migratory birds were considered to be the main dispersing agent of the virus at an intercontinental scale. European wintering wetlands, such as the Camargue (Rhône delta, France), are identified as potential hot spots for the risk of introduction and transmission of bird-borne diseases. In this study, we investigated the role of migratory waterbirds (mainly ducks) in the spread of HP H5N1 viruses. We combined molecular analysis of living and freshly killed birds with population surveillance (aerial censuses and death surveillance). We sampled 1345 birds belonging to 17 waterbird species (3 orders) in the Camargue between September 2005 and March 2006. The prevalence of AIV was 1.8%. We did not detect HP H5N1 virus. Population censuses did not reveal any population decreases nor abnormal mortalities. We discuss, in the light of these results, the implication of wild migratory ducks in the arrival of HP H5N1 AIV in Europe.


Asunto(s)
Anseriformes/virología , Subtipo H5N1 del Virus de la Influenza A/aislamiento & purificación , Gripe Aviar/epidemiología , Gripe Aviar/virología , Migración Animal , Animales , Heces/virología , Francia/epidemiología , Subtipo H5N1 del Virus de la Influenza A/patogenicidad
8.
Antivir Ther ; 16(4): 597-603, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21685548

RESUMEN

BACKGROUND: During the 2007-2008 season, A(H1N1) viruses naturally resistant to oseltamivir due to an H275Y substitution in the neuraminidase emerged and spread in the human population. The neuraminidase of 2007-2008 A(H1N1) viruses has an increased affinity for sialic acids as compared with the N1 of previously circulating viruses. METHODS: Using site-directed mutagenesis analysis and an enzymatic assay on cells transiently expressing the viral neuraminidase, the amino acid changes that could account for the particular enzymatic properties of the neuraminidase of 2007-2008 A(H1N1) viruses were explored. The affinity for the substrate (K(m)) and the inhibition constants for inhibitors (K(i)) were determined for wild-type and mutated neuraminidases. Reverse genetics was used to produce 6:2 reassortant viruses expressing haemagglutinin and neuraminidase derived from A(H1N1) viruses of the 2007-2008 season or from a previously circulating H1N1 virus, in an A/WSN/33 background. RESULTS: The D344N substitution characteristic of the N1 of 2007-2008 A(H1N1) viruses was identified as a major determinant of its increased affinity for sialic acids. According to the viral plaque phenotype of the 6:2 reassortant viruses, the H275Y mutation was deleterious when the surface glycoproteins were derived from the H1N1 virus isolated in 2004, but not when they were derived from A(H1N1) viruses of the 2007-2008 season. CONCLUSIONS: The D344N substitution, by modifying the enzymatic property of the N1, may have favoured the emergence and spread of viruses naturally resistant to oseltamivir.


Asunto(s)
Sustitución de Aminoácidos/genética , Antivirales/farmacología , Farmacorresistencia Viral/genética , Subtipo H1N1 del Virus de la Influenza A/enzimología , Neuraminidasa/genética , Ácidos Siálicos/farmacología , Antivirales/química , Antivirales/metabolismo , Línea Celular , Humanos , Subtipo H1N1 del Virus de la Influenza A/efectos de los fármacos , Subtipo H1N1 del Virus de la Influenza A/genética , Gripe Humana/virología , Modelos Moleculares , Mutagénesis Sitio-Dirigida , Neuraminidasa/química , Neuraminidasa/metabolismo , Oseltamivir/química , Oseltamivir/metabolismo , Oseltamivir/farmacología , Ácidos Siálicos/química , Ácidos Siálicos/metabolismo , Replicación Viral
9.
J Gene Med ; 5(12): 1028-38, 2003 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-14661178

RESUMEN

BACKGROUND: Recent studies have suggested that ex vivo expansion of autologous hematopoietic cells could be a therapy of choice for the treatment of bone marrow failure. We investigated the potential of a combined infusion of autologous ex vivo expanded hematopoietic cells with mesenchymal (MSCs) for the treatment of multi-organ failure syndrome following irradiation in a non-human primate model. METHODS: Hematopoietic cells and MSCs were expanded from bone marrow aspirates. MSCs were transduced with the gene encoding for the green fluorescent protein (e-GFP), in order to track them following infusion. Twelve animals were studied. Nine animals received total-body irradiation at 8 Gy from a neutron/gamma source thus resulting in heterogeneous exposure; three animals were sham-irradiated. The animals were treated with expanded hematopoietic stem cells and MSCs, expanded hematopoietic stem cells alone, or MSCs alone. Unmanipulated bone marrow cell transplants were used as controls. RESULTS: Depending on the neutron/gamma ratio, an acute radiation sickness of varying severity but of similar nature resulted. GFP-labeled cells were found in the injured muscle, skin, bone marrow and gut of the treated animals via PCR up to 82 days post-infusion. CONCLUSIONS: This is the first evidence of expanded MSCs homing in numerous tissues following a severe multi-organ injury in primates. Localization of the transduced MSCs correlated to the severity and geometry of irradiation. A repair process was observed in various tissues. The plasticity potential of the MSCs and their contribution to the repair process in vivo remains to be studied.


Asunto(s)
Movimiento Celular , Trasplante de Células Madre Hematopoyéticas , Trasplante de Células Madre Mesenquimatosas , Insuficiencia Multiorgánica/etiología , Insuficiencia Multiorgánica/terapia , Traumatismos por Radiación/complicaciones , Traumatismos por Radiación/terapia , Animales , Trasplante de Médula Ósea , Terapia Combinada , Marcadores Genéticos , Proteínas Fluorescentes Verdes , Proteínas Luminiscentes/genética , Macaca fascicularis , Masculino , Transducción Genética , Resultado del Tratamiento , Irradiación Corporal Total
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA